Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in CELLDEX THERAPEUTICS INC NEW
Current Value
$1.1M
Current Shares
35,948
Total Value Change
-$629,436
Total Shares Change
-11,869
New |
| 35,948 |
— |
| $1.1M |
| 0.0% |
| $28.94 |
35 |
| 2025-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $26.43 | 0 |
| 2025-Q3 | Decreased | 27,367 | -75.4% | $707,984 | 0.0% | $26.19 | 0 |
| 2025-Q2 | Increased | 111,399 | +18.9% | $2.3M | 0.0% | $20.29 | 31 |
| 2025-Q1 | Increased | 93,670 | +41.9% | $1.7M | 0.0% | $19.93 | 34 |
| 2024-Q4 | Increased | 66,034 | +2.3% | $1.7M | 0.0% | $25.12 | 26 |
| 2024-Q3 | Increased | 64,576 | +35.0% | $2.2M | 0.0% | $33.20 | 34 |
| 2024-Q2 | Decreased | 47,817 | -32.9% | $1.8M | 0.0% | $37.01 | 0 |